Skip to main content

Table 2 Relationship of SPARC expression in colon cancer tissues with clinicopathological parameters

From: Relationship and prognostic significance of SPARC and VEGF protein expression in colon cancer

  

Tumors cell

 

MSC

 

Parameters

 

low reactivity high reactivity

P value

low reactivity high reactivity

P value

  

n

%

n

%

 

n

%

n

%

 

Agea

     

0.379

    

0.904

< 59

48

32

66.7

16

33.3

 

26

54.2

22

45.8

 

≥ 59

66

49

74.2

17

25.8

 

35

53.0

31

47.0

 

Gender

     

0.276

    

0.276

men

54

41

75.9

13

24.1

 

26

48.1

28

51.9

 

women

60

40

66.7

20

33.3

 

35

58.3

25

41.7

 

Tumor sizeb

     

0.222

    

0.658

< 5.0

52

34

65.4

18

34.6

 

29

55.8

23

44.2

 

≥ 5.0

62

47

75.8

15

24.2

 

32

51.6

30

48.4

 

Localization

     

0.140

    

0.926

colon ascendens

27

22

81.5

5

18.5

 

14

51.9

13

48.1

 

flexura hepatica

22

17

77.3

5

22.7

 

12

54.5

10

45.5

 

colon transversum

6

6

100

0

0

 

3

50.0

3

50.0

 

flexura lienalis

8

6

75.0

2

25.0

 

3

37.5

5

62.5

 

colon descendens

6

3

50.0

3

50.0

 

4

66.7

2

33.3

 

colon sigmoideum

45

27

60.0

18

40.0

 

25

55.6

20

44.4

 

Tumor differentiation

     

0.930

    

0.046

low

16

12

75.0

4

25.0

 

4

25.0

12

75.0

 

moderate

68

48

70.6

20

29.1

 

39

57.4

29

42.6

 

high

30

21

70.0

9

30.0

 

18

60.0

12

40.0

 

Lymph node metastasis

     

0.462

    

0.013

N0

65

44

67.7

21

32.3

 

28

43.1

37

56.9

 

N1

36

26

72.2

10

27.8

 

22

61.1

14

38.9

 

N2

13

11

84.6

2

15.4

 

11

84.6

2

15.4

 

R/DMc

     

0.490

    

0.746

Yes

23

15

65.2

8

34.8

 

13

56.5

10

43.5

 

No

91

66

72.5

25

27.5

 

48

52.7

43

47.3

 

L/infiltrationd

     

0.626

    

0.678

Yes

41

28

68.3

13

21.7

 

23

56.1

18

43.9

 

No

73

53

72.6

20

27.4

 

38

52.1

35

47.9

 

depth of invasion

     

0.459

    

0.850

T2

15

12

80.0

3

20.0

 

8

53.3

7

46.7

 

T3

88

60

68.2

28

31.8

 

48

54.5

40

45.5

 

T4

11

9

81.8

2

18.2

 

5

45.5

6

54.5

 

Distant metastasis

     

0.504

    

0.797

M0

102

71

69.6

31

30.4

 

55

53.9

47

46.1

 

M1

12

10

83.3

2

16.7

 

6

50.0

6

50.0

 

TNM staging

     

0.431

    

0.297

I

11

9

81.8

2

22.2

 

5

45.5

6

54.5

 

II

47

30

63.8

17

36.2

 

21

44.7

26

55.3

 

III

44

32

72.7

12

27.3

 

28

63.6

16

36.4

 

IV

12

10

83.3

2

16.7

 

7

58.3

5

41.7

 
  1. a median, 59 years; b mean, 5.0 cm; c R/DM-Recurrence/distant metastasis;
  2. d lymphocytic infiltration in the tumor interstitial